Adaptive Biotechnologies Corp (ADPT) Q3 2026 Earnings Call Highlights: First Profitable Quarter ...
Adaptive Biotechnologies Corp (ADPT) posted $83.9 million in quarterly revenue, swung to positive adjusted EBITDA of $14.3 million, and raised full-year MRD guidance on strong ClonoSeq volume growth. Related Stocks: ADPT ,